Skip to content

Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial

Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00386477
Enrollment
300
Registered
2006-10-11
Start date
2006-09-30
Completion date
2009-05-31
Last updated
2010-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section, Endometritis, Surgical Wound Infection

Keywords

Povidone iodine, postoperative infection, presurgical cleansing

Brief summary

The objective of the project is to find out whether cleansing the vagina before a cesarean delivery decreases the risk of complications and infections after having the baby. If this is the case, cleansing the vagina before cesarean delivery can help improve outcomes for many women and make their early postpartum recovery much more pleasant, giving a healthier start for the family.

Detailed description

Infectious morbidity frequently complicates cesarean delivery. Endometritis can complicate the postoperative course of a cesarean delivery 6-27% of the time. This complication, up to 10 times more frequent than after vaginal delivery, can lead to serious complications. Additionally, cesarean deliveries are frequently complicated by maternal fever and wound complications including seroma, hematoma, infection, and separation. These morbidities can lead to significant delay in a return to normal function. Our study will randomize 1000 women who are about to undergo a cesarean delivery into one of two groups. The control group will receive the standard surgical preparation of the abdomen alone, the current standard pre-cesarean preparation. The other group will also receive a povidone iodine washing/scrub of the vagina before the cesarean delivery. Maternal and surgical variables will be recorded. At one months postpartum, maternal outpatient data will be reviewed and the incidence of postpartum uterine infection, wound separations, and other wound and infectious complications will be determined and compared between the two treatment groups. Comparison: Women receiving standard surgical abdominal cleansing versus women receiving standard abdominal and preoperative vaginal cleansing before cesarean delivery.

Interventions

PROCEDUREVaginal cleansing before cesarean delivery

Cleansing vagina with 1% betadine scrub before cesarean.

Sponsors

Indiana University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Woman undergoing cesarean delivery * At least 18 years of age

Exclusion criteria

* Allergy to iodine containing solutions * Planned cesarean hysterectomy * Prisoner

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Experienced Composite Endometritis Plus Wound Complications.1 monthEndometritis was diagnosed clinically as uterine pain and fever requireing antibiotics. Wound complications included wound infection, seroma, hematoma, or separation.

Countries

United States

Participant flow

Participants by arm

ArmCount
Vag Prep
Vagina cleansed with betadine vaginal scrub sticks prior to performing cesarean
155
Control
No vaginal cleansing or sham wash performed.
145
Total300

Baseline characteristics

CharacteristicVag PrepControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
155 Participants145 Participants300 Participants
Age Continuous26.8 years
STANDARD_DEVIATION 5.9
26.6 years
STANDARD_DEVIATION 5.7
26.7 years
STANDARD_DEVIATION 5.8
Race/Ethnicity, Customized155 participants145 participants300 participants
Region of Enrollment
United States
155 participants145 participants300 participants
Sex: Female, Male
Female
155 Participants145 Participants300 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1550 / 145
serious
Total, serious adverse events
0 / 1550 / 145

Outcome results

Primary

Number of Participants Who Experienced Composite Endometritis Plus Wound Complications.

Endometritis was diagnosed clinically as uterine pain and fever requireing antibiotics. Wound complications included wound infection, seroma, hematoma, or separation.

Time frame: 1 month

Population: Randomization

ArmMeasureValue (NUMBER)
Vag PrepNumber of Participants Who Experienced Composite Endometritis Plus Wound Complications.10 participants
ControlNumber of Participants Who Experienced Composite Endometritis Plus Wound Complications.17 participants
p-value: 0.1195% CI: [0.26, 1.11]Chi-squared, Corrected

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026